Search
for
Sort by
Research 661–690 of 1000+
- Cold Atmospheric Plasma for Breast Cancer
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Possible role of β‐hydroxybutyrate in inducing inflammation in alopecia areata
- Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling
- SMC-specific IGF1 suppresses a 45 kDa LAMP2 isoform to mediate the anti-atherosclerotic effect of ferulic acid
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Correlation between changes of amino acid spectrum and alopecia in patients with obesity undergoing bariatric surgery: a prospective cohort study
- Ivarmacitinib stimulates hair regrowth in severe alopecia areata
- Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
- Patient factors influencing dermal filler complications: prevention, assessment, and treatment
- The Pharmacology of Regenerative Medicine
- Cutaneous Retinoic Acid Levels Determine Hair Follicle Development and Downgrowth
- Effects of Microwave-Assisted Opuntia humifusa Extract in Inhibiting the Impacts of Particulate Matter on Human Keratinocyte Skin Cell
- Native and engineered extracellular vesicles for wound healing
- Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
- WS PRO 160 I 120 mg (a combination of sabal and urtica extract) in patients with LUTS related to BPH
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Androgenetic alopecia – Update 2022
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Promising anitidiabetic potential of Cuscuta reflexa leaves methanol extract in alloxan-induced diabetic rats
- 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Hair Manganese as a Marker of Cardiometabolic Status Rather than Coronary Artery Disease Severity—An Exploratory Pilot Study
- Management of Sexual Dysfunction in Postmenopausal Breast Cancer Patients Taking Adjuvant Aromatase Inhibitor Therapy
- Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
- Biologics in the management of childhood atopic dermatitis
- Diagnostic value of the diagonal earlobe crease in combination with lipoprotein(a) in coronary heart disease